Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.2875
Abstract: Previous studies have demonstrated the role of abnormal alternative splicing (AS) in tumor progression. This study examines the prognostic index (PI) of alternative splices (ASs) in patients with hepatocellular carcinoma (HCC). The clinical features and… read more here.
Keywords: hepatocellular carcinoma; analysis; patients hcc; cox regression ... See more keywords
Is It Time to Reconsider the Milan Criteria for Selecting Patients With Hepatocellular Carcinoma for Deceased‐Donor Liver Transplantation?
Sign Up to like & getrecommendations! Published in 2019 at "Hepatology"
DOI: 10.1002/hep.30278
Abstract: Liver transplantation (LT) is considered the optimal treatment for hepatocellular carcinoma (HCC) because it removes tumor as well as the underlying cirrhotic liver. Because of a global organ shortage, LT for patients with HCC is… read more here.
Keywords: hepatocellular carcinoma; milan criteria; patients hcc; liver transplantation ... See more keywords
Fully automated AI-based splenic segmentation for predicting survival and estimating the risk of hepatic decompensation in TACE patients with HCC
Sign Up to like & getrecommendations! Published in 2022 at "European Radiology"
DOI: 10.1007/s00330-022-08737-z
Abstract: Splenic volume (SV) was proposed as a relevant prognostic factor for patients with hepatocellular carcinoma (HCC). We trained a deep-learning algorithm to fully automatically assess SV based on computed tomography (CT) scans. Then, we investigated… read more here.
Keywords: risk hepatic; hepatic decompensation; patients hcc; tace ... See more keywords
Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis
Sign Up to like & getrecommendations! Published in 2019 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-019-05701-8
Abstract: ObjectivesTransarterial chemoembolization (TACE) improves the survival of patients with hepatocellular carcinoma (HCC); however, TACE treatment outcomes of patients with treatment-naïve HCC (TN-HCC) and those with recurrent HCC after curative resection (R-HCC) have not yet been… read more here.
Keywords: hepatocellular carcinoma; hcc; tace; analysis ... See more keywords
Liver Transplantation and Liver Resection for Cirrhotic Patients with Hepatocellular Carcinoma: Comparison of Long-Term Survivals
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Gastrointestinal Surgery"
DOI: 10.1007/s11605-018-3690-4
Abstract: BackgroundBoth liver transplantation (LT) and liver resection (LR) represent curative treatment options for hepatocellular carcinoma (HCC) in patients with liver cirrhosis. In this study, we have compared outcomes between historical and more recent patient cohorts… read more here.
Keywords: hepatocellular carcinoma; liver resection; patients hcc; liver transplantation ... See more keywords
Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.
Sign Up to like & getrecommendations! Published in 2018 at "Clinics and research in hepatology and gastroenterology"
DOI: 10.1016/j.clinre.2018.02.003
Abstract: BACKGROUND We aimed to identify the independent predictive factors of microvascular invasion (MVI) for curative resection of HCC and to investigate the impacts of MVI and HBeAg on long-term recurrence and survival after resection. METHODS… read more here.
Keywords: group; hcc mvi; patients hcc; microvascular invasion ... See more keywords
Transarterial radioembolization with Yttrium-90: current status and future prospects
Sign Up to like & getrecommendations! Published in 2020 at "Gastroenterology Report"
DOI: 10.1093/gastro/goz074
Abstract: In recent years, transarterial radioembolization (TARE) with Yttrium-90 (Y90) has emerged as a technique for treating malignant neoplasms in the liver. Compared with other locoregional therapies, such as transarterial chemoembolization (TACE), patients who underwent TARE… read more here.
Keywords: tare; treatment; transarterial radioembolization; group ... See more keywords
MDR1 gene polymorphism correlated with pathological characteristics and prognosis in patients with primary hepatocellular carcinoma receiving interventional therapy
Sign Up to like & getrecommendations! Published in 2019 at "Anti-Cancer Drugs"
DOI: 10.1097/cad.0000000000000680
Abstract: The aim of this study was to explore the relationship of multidrug resistance gene 1 (MDR1) C1236T and C3435T single nucleotides polymorphisms (SNPs) with hepatocellular carcinoma (HCC) pathological features and prognosis. A total of 143… read more here.
Keywords: hepatocellular carcinoma; patients hcc; tumor; portal vein ... See more keywords
Multidisciplinary Management of Hepatocellular Carcinoma Improves Access to Therapy and Patient Survival
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Gastroenterology"
DOI: 10.1097/mcg.0000000000000825
Abstract: Background: Given the complexity of managing hepatocellular carcinoma (HCC), it is widely accepted that a multidisciplinary team approach (tumor boards) offers the best approach to individualize therapy. The aim of this study was to determine… read more here.
Keywords: hepatocellular carcinoma; managed mdtb; patients hcc; therapy ... See more keywords
FIB-4 index serves as a noninvasive prognostic biomarker in patients with hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000013696
Abstract: Background: Liver fibrosis index FIB-4 has been reported to be linked with hepatocellular carcinoma (HCC) prognosis, but the results were not consistent. This study aimed to synthetically explore the relationship between FIB-4 and clinical outcomes… read more here.
Keywords: hepatocellular carcinoma; index; index serves; patients hcc ... See more keywords
P52 Elevated intratumour neutrophils associate with improved treatment responses and prognosis in patients with HCC
Sign Up to like & getrecommendations! Published in 2020 at "Gut"
DOI: 10.1136/gutjnl-2020-basl.62
Abstract: Hepatocellular carcinomas (HCC) develop on a background of chronic liver inflammation. Neutrophils are key mediators of the tumour immune microenvironment. Elevated circulating neutrophils in HCC patients is independently associated with poorer survival, while neutrophil depletion… read more here.
Keywords: number neutrophils; patients hcc; treatment; intratumour neutrophils ... See more keywords